Titre : Angiofibrome

Angiofibrome : Questions médicales fréquentes

Termes MeSH sélectionnés :

Neoplasm Recurrence, Local

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
Angiofibroma
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Angiofibrome : Questions médicales les plus fréquentes", "headline": "Angiofibrome : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Angiofibrome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-06", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Angiofibrome" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs du tissu vasculaire", "url": "https://questionsmedicales.fr/mesh/D009383", "about": { "@type": "MedicalCondition", "name": "Tumeurs du tissu vasculaire", "code": { "@type": "MedicalCode", "code": "D009383", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.557.645" } } }, "about": { "@type": "MedicalCondition", "name": "Angiofibrome", "alternateName": "Angiofibroma", "code": { "@type": "MedicalCode", "code": "D018322", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rakesh Kumar", "url": "https://questionsmedicales.fr/author/Rakesh%20Kumar", "affiliation": { "@type": "Organization", "name": "Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India." } }, { "@type": "Person", "name": "Anupam Mishra", "url": "https://questionsmedicales.fr/author/Anupam%20Mishra", "affiliation": { "@type": "Organization", "name": "Department of Otorhinolaryngology and Head and Neck Surgery, King George's Medical University, Lucknow, India. Electronic address: amishra_ent@yahoo.com." } }, { "@type": "Person", "name": "Alok Thakar", "url": "https://questionsmedicales.fr/author/Alok%20Thakar", "affiliation": { "@type": "Organization", "name": "Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India." } }, { "@type": "Person", "name": "Giacomo Bertazzoni", "url": "https://questionsmedicales.fr/author/Giacomo%20Bertazzoni", "affiliation": { "@type": "Organization", "name": "Unit of Otorhinolaryngology - Head and Neck Surgery, University of Brescia, Brescia, Italy." } }, { "@type": "Person", "name": "Alberto Schreiber", "url": "https://questionsmedicales.fr/author/Alberto%20Schreiber", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.", "datePublished": "2022-11-13", "url": "https://questionsmedicales.fr/article/36371582", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1245/s10434-022-12760-1" } }, { "@type": "ScholarlyArticle", "name": "Feasibility of local therapy for recurrent pancreatic cancer.", "datePublished": "2022-05-24", "url": "https://questionsmedicales.fr/article/35641368", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.pan.2022.05.004" } }, { "@type": "ScholarlyArticle", "name": "Ultrasound Assessment of Skin Tumors Local Recurrence.", "datePublished": "2023-05-17", "url": "https://questionsmedicales.fr/article/37195073", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jum.16255" } }, { "@type": "ScholarlyArticle", "name": "Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.", "datePublished": "2023-06-26", "url": "https://questionsmedicales.fr/article/37442715", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejso.2023.06.023" } }, { "@type": "ScholarlyArticle", "name": "Intraparenchymal metastases as a cause for local recurrence of pancreatic cancer.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36371607", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/his.14839" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://questionsmedicales.fr/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs par type histologique", "item": "https://questionsmedicales.fr/mesh/D009370" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs du tissu vasculaire", "item": "https://questionsmedicales.fr/mesh/D009383" }, { "@type": "ListItem", "position": 5, "name": "Angiofibrome", "item": "https://questionsmedicales.fr/mesh/D018322" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Angiofibrome - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Angiofibrome", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-29", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Angiofibrome", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D018322?mesh_terms=Neoplasm+Recurrence,+Local#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 31/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Rakesh Kumar

3 publications dans cette catégorie

Affiliations :
  • Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
Publications dans "Angiofibrome" :

Anupam Mishra

3 publications dans cette catégorie

Affiliations :
  • Department of Otorhinolaryngology and Head and Neck Surgery, King George's Medical University, Lucknow, India. Electronic address: amishra_ent@yahoo.com.
Publications dans "Angiofibrome" :

Alok Thakar

2 publications dans cette catégorie

Affiliations :
  • Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
Publications dans "Angiofibrome" :

Giacomo Bertazzoni

2 publications dans cette catégorie

Affiliations :
  • Unit of Otorhinolaryngology - Head and Neck Surgery, University of Brescia, Brescia, Italy.
Publications dans "Angiofibrome" :

Alberto Schreiber

2 publications dans cette catégorie

Publications dans "Angiofibrome" :

Marco Ferrari

2 publications dans cette catégorie

Publications dans "Angiofibrome" :

Piero Nicolai

2 publications dans cette catégorie

Publications dans "Angiofibrome" :

Bernhard Schick

2 publications dans cette catégorie

Affiliations :
  • Department of Otolaryngology, Saarland University Medical Center, 66421 Homburg, Germany.
Publications dans "Angiofibrome" :

Silke Wemmert

2 publications dans cette catégorie

Affiliations :
  • Department of Otolaryngology, Saarland University Medical Center, 66421 Homburg, Germany.
Publications dans "Angiofibrome" :

Line Hoeltgen

2 publications dans cette catégorie

Affiliations :
  • Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Thomas Tessonnier

2 publications dans cette catégorie

Affiliations :
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Eva Meixner

2 publications dans cette catégorie

Affiliations :
  • Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Ji-Young Kim

2 publications dans cette catégorie

Affiliations :
  • Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Maximilian Deng

2 publications dans cette catégorie

Affiliations :
  • Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Katharina Seidensaal

2 publications dans cette catégorie

Affiliations :
  • Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Thomas Held

2 publications dans cette catégorie

Affiliations :
  • Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Klaus Herfarth

2 publications dans cette catégorie

Affiliations :
  • Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Semi Harrabi

2 publications dans cette catégorie

Affiliations :
  • Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Pandey Amita

2 publications dans cette catégorie

Affiliations :
  • Department of Obstetrics/Gynecology, King George's Medical University, Aliganj, Lucknow India.
Publications dans "Angiofibrome" :

Michael J Cunningham

2 publications dans cette catégorie

Affiliations :
  • Department of Otolaryngology and Communication Enhancement, Boston Children's Hospital, Boston, Massachusetts.
  • Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, U.S.A.
Publications dans "Angiofibrome" :

Sources (10000 au total)

Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.

Little information is available about the clinical and pathologic characteristics of local recurrence (LR) after nipple-sparing mastectomy according to the locations of LR.... This study classified 99 patients into the following two groups according to the location of LR after nipple-sparing mastectomy: nipple-areolar recurrence (NAR) group and other locations of LR (oLR) g... For about half of the patients (44.4 %) with NAR, the primary cancer was estrogen receptor (ER)-negative and human epidermal growth factor receptor 2 (HER2)-positive. Conversely, in most of the patien... This multi-institutional retrospective study demonstrated that the features of NAR, such as the characteristics of the primary and recurrent tumors and the prognostic factors after LR resection, were ...

Feasibility of local therapy for recurrent pancreatic cancer.

Despite advances in perioperative management, recurrence after curative pancreatectomy is a critical issue in the treatment of pancreatic ductal adenocarcinoma (PDAC). The significance of local therap... We reviewed the medical records of patients with PDAC who underwent curative resection at our institution between January 2009 and December 2019. We examined the patterns of relapse and assessed the c... A total of 246 patients with PDAC who underwent R0 or R1 resection were included in this study. The 3-year overall survival (OS) rate was 39.8%, and the 1-year recurrence-free survival rate was 51.2% ... Our results suggest that a multimodal approach may improve the clinical outcomes of patients with recurrent PDAC....

Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.

Pathological factors that influence and predict survival following pelvic exenteration (PE) for locally advanced (LARC) or locally recurrent rectal cancer (LRRC), especially LRRC, remain poorly unders... A retrospective cohort study was performed for all patients undergoing a curative PE for LARC or LRRC between 2008 and 2021 at a tertiary referral UK specialist colorectal hospital. Cox regression ana... 388 patients were included in the analysis with 256 resections for LARC and 132 for LRRC. 62.4% of patients were male with a median age of 59 years (IQR 49-67). 247 (64%) partial pelvic exenterations ... A positive resection margin and poorly differentiated tumours are significant negative prognostic markers for survival and recurrence in LARC. The results of this study support the need to look for al...

Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.

The initial approach to the treatment of desmoid tumors has changed from surgical resection to watchful waiting. However, surgery is still sometimes considered for some patients, and it is likely that... We sought to explore whether a combined molecular and clinical prognostic model for relapse in patients with desmoid tumors treated with surgery would allow us to identify patients who might do well w... This was a retrospective, single-center study of 107 patients with desmoid tumors who were surgically treated between January 1980 and December 2015, with a median follow-up of 106 months (range 7 to ... The multivariable analysis showed that S45F mutations (hazard ratio 5.25 [95% confidence interval 2.27 to 12.15]; p < 0.001) and tumor in the extremities (HR 3.15 [95% CI 1.35 to 7.33]; p = 0.008) wer... CTNNB1 S45F mutations combined with other clinical variables are a potential prognostic biomarker associated with the risk of relapse in patients with desmoid tumors. The developed nomogram is simple ... Level III, therapeutic study....

Risk Factors of Second Local Recurrence in Surgically Treated Recurrent Brain Metastases: An Exploratory Analysis.

A first local recurrence is common after resection or radiotherapy for brain metastasis (BM). However, patients with BMs can develop multiple local recurrences over time. Published data on second loca... Patients were identified from a database at Brigham and Women's Hospital in Boston. Hazard ratios and 95% confidence intervals for predictors of a second local recurrence were computed using a Cox pro... Of 170 identified surgically treated first locally recurrent lesions, 74 (43.5%) progressed to second locally recurrent lesions at a median of 7 months after craniotomy. Subtotal resection of the firs... A second local recurrence occurred after 43.5% of craniotomies for first recurrent lesions. Subtotal resection and infratentorial location were the strongest risk factors for worse second local recurr...

Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery.

The current study was undertaken to provide more detailed prognostic models for early prediction of local recurrences and local recurrence free survival (RFS) using different radiologic and pathologic... One hundred patients with locally advanced rectal carcinomas decided to receive neoadjuvant CRT were retrospectively recruited, Hazard ratios (HR) were determined in the two cox regression models and ... HR of 1st group of models: T+N, T+N+G, T+N+G+S, T+N+G+S+PNI, and T+N+G+S+PNI+R were summated and categorized into scores, these scores were significantly correlated with the risk of recurrence (Somer'... We propose that the addition of biologic factors to staging of rectal cancer provide precise stratification and association with local recurrences in patients received preoperative CRT....

Surgery of resectable local recurrence following colorectal cancer: Compartmental surgery improves local control.

This study aims to identify prognostic factors and define the best extent of surgery for optimizing treatment of local recurrence (LR) following colorectal cancer (CRC).... An institutional database of consecutive patients who underwent radical resection (R0/R1) of LR following CRC was analyzed prospectively from 2010 to 2021 at one tertiary cancer center.... In this study, 75 patients were included with LR following CRC and analyzed. Patients were categorized as compartmental resections (CompRe) (n = 47) if all adjacent organs were systematically removed,... Complete compartmental surgery is safe and improves local control. Optimal LR resection needs to remove all contiguous organs, with or without tumor involvement....

Recurrent RET fusions in fibrosarcoma-like neoplasms in adult viscera: expanding the clinicopathological and genetic spectrum.

RET-fused mesenchymal neoplasms mostly affect the soft tissue of paediatric patients. Given their responsiveness to selective RET inhibitors, it remains critical to identify those extraordinary cases ... Clinicopathological features were assessed and partner agnostic targeted next-generation sequencing on clinically validated platforms were performed. The patients were 18, 53, and 55 years old and inc... Our study expands the clinicopathological and genetic spectrum of mesenchymal neoplasms associated with RET fusions....